Evidence
Themed Review

Living with Covid19 - webinars

The NIHR Centre for Engagement and Dissemination has recently published the 'Living with Covid19' review compiling the current state of knowledge on ongoing Covid19 symptoms. Our review is seeking to frame a dialogue with the public, health and social care professionals, researchers, service providers and policy makers to better understand the issues around living with ...

Alert

National infection control campaigns led to a rapid decline in superbug infections in UK intensive care units

In the early 2000s, bacteria that are resistant to antibiotics were widespread in UK hospitals and a strain of methicillin-resistant Staphylococcus aureus (MRSA) posed a major threat to public health. This led to nationwide infection control programmes in the mid-2000s, with a rapid decline in rates in NHS hospitals over the following decade. This study ...

Alert

Testing for hepatitis in A&E departments is likely to be cost-effective in many areas of the UK

Accident and Emergency (A&E) departments may be a cost-effective location for testing for hepatitis, new research has found. Rates of hepatitis are higher among A&E patients than in the general population. This is because hepatitis is more common among marginalised communities - including people who are homeless or who inject drugs - and they attend ...

Themed Review

Living with Covid19

A dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid). Key Messages Introduction What are we aiming to achieve with our Living with Covid19 review? Drawing on people’s experience How many people live with ongoing Covid19? Symptoms Diagnostic uncertainty Research into living with Covid19 Capturing the experience of ‘Long Covid’ Services ...

Alert

Brain and nerve complications are more common than expected in younger patients with severe COVID-19

People aged under 60 who are hospitalised with COVID-19 are more likely than expected to experience severe psychiatric symptoms. Research found that altered mental states such as psychosis are being reported in these younger patients.  It confirmed that strokes and other neurological symptoms are common in severe COVID-19. An initial study included 153 cases reported ...

Alert

Tackling fear and misinformation may help increase hepatitis C testing in prison

Liver disease caused by the hepatitis C virus (HCV) is a major public health burden. The World Health Organisation is aiming to eliminate HCV as a public health problem by 2030 and testing in prisons is central to this campaign. People entering prison are asked to have a test for blood-borne viruses including HCV, but ...

Alert

Community-based medicine collection improves access to lifesaving HIV treatment in South Africa

A programme in South Africa is successfully shifting the location of treatments for long term conditions from the clinic to the community. It is the largest programme of its kind in the world and a new study highlights the benefits to people living with HIV. The programme is called Centralised Chronic Medication Dispensing and Distribution ...

Collection

Mental health and COVID-19

The impact of COVID-19 pandemic and the constraints it has imposed on people is an issue of interest and concern to patients, service users, carers and health and social care professionals alike. In pandemic conditions it is likely that people’s existing mental health problems may get worse. Mental health may also decline because of social ...

Alert

High rates of delirium, persistent fatigue and post-traumatic stress disorder were common after severe infection in previous coronavirus outbreaks

Little is known about the mental health consequences of severe COVID-19 illness because it is caused by a new coronavirus. Previous outbreaks caused by other coronaviruses (severe acute respiratory syndrome, SARS, and Middle East respiratory syndrome, MERS) may provide insights into ongoing problems after recovery from severe illness.  Researchers looked at reports of psychiatric problems ...

Alert

Measles vaccine still effective if given to infants under nine months old

A first vaccination dose against measles is a safe and somewhat effective option if given to infants earlier than usual, and before the age of nine months. However, vaccine effectiveness does increase when administered at older ages, as currently. Two doses of measles-containing vaccines are recommended as part of a childhood immunisation programme. In countries ...

94 Results 10 20 30 Results per page